Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
KemPharm
About
KemPharm is a biopharmaceutical company focused on discovering and developing therapies for pain, ADHD, and other CNS diseases.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $3.48M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
KemPharm is a development-stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse-resistant opioid pain relievers. Its drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 27, 2009 | Series B | $3.48M | 1 |
BP Growth Partners
|
— | Detail |
| Jul 14, 2008 | Series A | $647K | 1 |
BP Growth Partners
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
BP Growth Partners
|
Yes | Series B |
